
Matthew McCord
Associate Program Director, Neuropathology Fellowship · University of Virginia Medical Center
Credentials: · · · · · ·
History
PresentNeuropathology Fellowship · University of Virginia Medical Center


2022–2024


- 2010–2014
Research
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma
Nature Cancer · 2021 · 95 citations
Nature Communications · 2024 · 89 citations
Targeting WNT Signaling for Multifaceted Glioblastoma Therapy
Review · Frontiers in Cellular Neuroscience · 2017 · First of 4 authors · 87 citations

19 papers

9 papers · 6 as a fellow

7 papers

7 papers

7 papers

6 papers

6 papers

5 papers
Grants
- 2022–2025
Mechanisms and Therapeutic Implications of Temozolomide Resistance in Glioblastoma
National Cancer Institute · F32
Contact PI · $147.8K · Northwestern University


